A Prospective Phase II Efficacy and Safety Study of Anlotinib in Metastatic or Locally Advanced Pheochromocytoma/ Paraganglioma : Open-label Single-arm, Exploratory Trial.
Latest Information Update: 04 Jan 2024
At a glance
- Drugs Catequentinib (Primary)
- Indications Paraganglioma; Phaeochromocytoma
- Focus Therapeutic Use
- Acronyms EASOAIPPGL
- 01 Dec 2021 New trial record